A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 445 participants.

Also called NCT03998319

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose other
Phase
Phase 3
Enrolled
  • 445 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03998319
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03998319. Randomized; quadruple masking; primary purpose other. Start 2021-10-14 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
Acronym
RESTORE-MI
Condition
STEMI
Condition
Elevated IMR (>32)
Intervention (Drug)
Tenecteplase (1/3 systemic weight based dose)
Intervention (Other)
Sterile water for injection (WFI)
Lead sponsor
University of Sydney (class: other)

Record details

Record id
cardio:ct-nct03998319
Content hash
8da30157beab1e0d23f988c2f5d803e3ac02c78887c3af015a16f28db91aa519